Calcitonin and bipolar disorder: A hypothesis revisited

Journal of Psychiatry and Neuroscience

Volumn 23, Issue 2, 1998, Pages 109-117

  Vik, Astrid ^a   Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; DIACYLGLYCEROL; GLUTAMIC ACID; HISTAMINE; INOSITOL 1 PHOSPHATASE; INOSITOL PHOSPHATE; INOSITOL TRISPHOSPHATE; LITHIUM; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN KINASE C; PROTIRELIN;

CALCIUM TRANSPORT; DRUG MECHANISM; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL MEMBRANE; NONHUMAN; REVIEW; SECOND MESSENGER;

ANIMALS; BIPOLAR DISORDER; CALCITONIN; HUMANS;

EID: 0031925102     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Carman J S, Wyatt ES, Smith W, Post RM, Ballenger ES. Calcium and calcitonin in bipolar affective disorder. In: Ballenger JC, Post RM, editors. Neurobiology of mood disorders. Baltimore: Williams & Wilkins; 1984.
2. Silva OL, Becker KL. Immunoreactive calcitonin in extra-thyroidal tissues. In: Pecile A, editor. Calcitonin 1980: chemistry, physiology, pharmacology and clinical aspects. Proceedings of an international Symposium on Calcitonin; 1980 Oct 15-17; Milan, Italy, p. 144-53.
3. Hoovers JMN, Redeker E, Speleman F, Hoppener JWM, Bhola S, Bliek J, et al. High-resolution chromosomal localization of the human calcitonin/CGRP/IAPP gene family members. Genomics 1993;15:525-9.
4. Sexton PMJ, McKenzie JS, Mendelsohn O. Evidence for a new sub-class of calcitonin/calcitonin gene-related peptide binding site in the rat brain. Neurochem Int 1988;12:323-35.
5. Skofitsch G, Jacobowitz DM. Calcitonin and calcitonin gene related peptide binding sites in the rat central nervous system. Ann N Y Acad Sci 1992;657:420-2.
6. Fischer JA, Sagar SM, Martin JB Characterization and regional distribution of calcitonin binding sites in the rat brain. Life Sci 1981;29:663-71.
7. Olgiati VR, Guidobono F, Netti C, Pecile A. Localization of calcitonin binding sites in rat central nervous system: evidence of its neuroactivity. Brain Res 1982;265:209-15.
8. Henke H, Tobler PH, Fischer JA. Localization of salmon calcitonin binding sites in the rat brain by autoradiography. Brain Res 1983;272:373-7.
9. Twery MJ, Moss RL. Calcitonin and calcitonin gene-related peptide alter the excitability on neurons in the rat forebrain. Peptides 1985;6:373-8.
10. Tannenbaum GS, Goltzman D. Calcitonin gene-related peptide mimics calcitonin actions in brain on growth hormone release and feeding. Endocrinology 1985;116:2685-7.
11. Goltzman D, Mitchell J. Interaction of calcitonin and calcitonin gene-related peptide at receptor sites at target tissues. Science 1985;227:1343-5.
12. Krahn DD, Gosnell BA, Levine AS, Morley JE. Effects of calcitonin gene-related peptide on food intake. Peptides 1984;5:861-4.
13. Moore EE, Kuestner RE, Stroops D, Grant FJ, Mathewes SL, Braday CL, et al. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol 1995;9:954-68.
14. Nussenzveig DR, Thaw CN, Gershengorn MC. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. J Biol Chem 1994;269:28123-9.
15. Chakraborty M, Chatterjee D, Kellokumpu S, Rasmussen H, Baraon R. Cell-cycle dependent coupling of the calcitonin receptor to different G-proteins. Science 1991;251(4997):1078-81.
16. Dubovsky SL, Thomas M, Hijazi A, Murphy J. Intracellular calcium signaling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 1994;243:229-34.
17. Dubovsky SL, Murphy J, Christiano J, Lee C. The calcium second messenger system in bipolar disorders: data supporting new research directions. J Neuropsychiatry Clin Neurosci 1992;4:3-14.
18. Freidman E, Wang HY. Receptor-mediated activation of G-proteins is increased in post-mortem brains of bipolar affective disorder subjects. J Neurochem 1996;67:1145-52.
19. Lennox RH, Watson DG. Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. Clin Chem 1994;40:309-14.
20. Warsh JJ, Li PP. Second messenger systems and mood disorders. Curr Opin Psychiatry 1996;9:23-9.
21. Casebolt TM, Jope RS. Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex. Eur J Pharmacol 1987;140:245-6.
22. Casebolt TL, Jope RS. Effects of chronic lithium treatment on protein kinase C and cyclic AMP dependent protein phosphorylation. Biol Psychiatry 1991;25:329-10.
23. Judd AM, Kubota T, Kuan SI, Jarvis D, Spangelo BL, Macleod RM. Calcitonin decreases TRH stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production. Endocrinology 1990;127:191-9.
24. Clementi G, Favit A, Curreri R, Nicoletti F, Scapagnini U. Repeated calcitonin treatment reduces the stimulation of inositol phosholipid by norepinephrine and serotonin in rat hippocampus and cerebral cortex. Brain Res 1988;478:138-42.
25. Sortino MA, Canonico PL, Clementi G. Bimodal action of [Asu]eel-calcitonin on phoshoinositide hydrolysis in cultured anterior pituitary cells. Eur J Pharmacol 1991;207:345-50.
26. Sortino MA, Aleppo G, Scapagnini U, Canonico PL. Ipriflavone inhibits the phosphoinositide hydrolysis and Ca+ uptake in the osteoblast-like UMR-106 cells. Eur J Pharmacol 1992;226:273-7.
27. Epand RM, Stafford AR, Orlowski RC. Calcitonin inhibits the rise of intracellular calcium induced by thyrotropin-releasing hormone in GH3 cells. Cell Calcium 1989;10:145-9.
28. Nakhla AM, Latif A. Response of rat brain to calcitonin alteration. Brain Res 1982;238:489-93.
29. Nakhla AM, Majumdar AP. Calcitonin-mediated changes in plasma tryptophan and brain 5-HT and acetylcholinesterase activity in rats. Biochemistry J 1978;170(2):445-8.
30. Gaggi R, De Iasio R, Gianni AM. Relationships between the effects of peripherally administered salmon calcitonin on calcemia and brain biogenic amines. Jpn J Pharmacol 1989;51: 309-20.
31. Gaggi R, Chirivi L, Roncada P, Gianni AM. Calcitonin enhances the effects of nimodipine on biogenic amines of rat brain. Gen Pharmacol 1992;23(3):561-3.
32. Dupuy B, Peuchant E, Vitello S, Jensen R, Baghdiantz A, Blanquet P. Tryptophan and neutral amino acid concentrations in serum of rats after salmon calcitonin injection. Experientia 1983;39:294-6.
33. Nicosia S, Guidobono F, Musanti M, Pecile A. Inhibitory effects of calcitonin on adenylate cyclase activity in different rat brain areas. Life Sci 1986;39:2253-62.
34. Mork A, Geisler A. Effects of lithium ex vivo on the GTP-mediated inhibition of calcium-stimulated adenylate cyclase activity in rat brain. Eur J Pharmacol 1989;168:347-54.
35. Masana MI, Bitran JA, Hsiao JK, Mefford IN, Potter WZ. Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study. Brain Res 1990;538:333-6.
36. Manji HK, Potter WZ, Lennox RH. Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry 1995;52:531-3.
37. Post BM, Weiss SRB, Chuang DM. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol 1992;12:23S-35S.
38. Shimizu N, Omura Y. Calcitonin-induced anorexia in rats: evidence for its inhibitory action on lateral hypothalamic chemosensitive neurons. Brain Res 1985;367:128-40.
39. Prato A, Scapagnini U, Rapisarda E, Giuffrida R, Palmeri A, Caruso A, et al. Analgesic activity of a synthetic analogue of eel-calcitonin and its effect on the spontaneous activity of brainstem neurons in the rat. Neurosci Lett 1987;81:303-8.
40. Gerber U, Felix D, Felser M, Schaffner W. The effects of calcitonin on central neurons in the rat. Neurosci Lett 1985;60:343-8.
41. Sawada M, Ichinose M, Ishikawa S, Sasayama Y. Calcitonin induces a decreased Na+ conductance in identified neurons of aplysia. J Neurosci Res 1993:36:200-8.
42. Bishop GA. Calcitonin gene-related peptide modulates neuronal activity in the mammalian cerebellar cortex. Neuropeptides 1995;28:85-97.
43. Shinnick-Gallagher P, Twery M. Calcitonin and calcitonin-gene related peptide: credentials as neurotransmitters. In: Cooper CW, editor. Current research on calcium-regulating hormones. Austin, Tex.: University of Texas Press; 1987. p. 139-46.
44. Sobaniec W, Kulak W. Anticonvulsive properties of calcitonin in rats. Eur Neuropsychopharmacol 1992;2:443-6.
45. Maeda Y, Yamada K, Hasegawa T, Nabeshima T. Neuronal mechanism of the inhibitory effect of calcitonin on N-methyl-D-aspartate-inciuced aversive behavior. Eur J Pharmacol 1994;275:163-70.
46. Maeda Y, Nakamura T, Hasegawa T, Furakawa H, Nabeshima T. Effect of salmon calcitonin on the lethality of quinolinic acid, an excitatory amino acid. Res Commun Chem Pathol Pharmacol 1992;77:191-9.
47. Okamoto Y, Kagaya A, Shinno H, Motohashi N, Yamawaki S. Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci 1994;56:327-32.
48. Kusumakar V, Yatham LN. An open label study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-8.
49. Shah GV, Kennedy D, Dockter ME, Crowley WR. Calcitonin inhibits thyrotropin-releasing hormone-induced increases in cytosolic Ca2+ isolated rat anterior pituitary cells. Endocrinology 1990;127:613-20.
50. Levine AS, Morley JE. Reduction of feeding in rats by calcitonin. Brain Res 1981;222:187-91.
51. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990.
52. Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 1994;35:121-7.
53. Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry 1995;56(suppl 2):38-48.
54. Twery MJ, Cooper CW, Mailman RB. Calcitonin depresses amphetamine-induced locomotor activity. Pharmacol Biochem Behav 1983;18:857-62.
55. Clementi G, Drago F, Amico-Roxas M, Prato A, Rapisarda E, Nicoletti F, et al. Central actions of calcitonin and parathyroid hormone. In: Pecile A, editor. Calcitonin 1984: chemistry, physiology, pharmacology and clinical aspects. Proceedings of an International Symposium on Calcitonin; 1984 Oct 2-4; Milan, Italy, p. 279-86.
56. Nicoletti F, Clementi G, Patti F, Canonico PL, Di Giorgio RM, Maters M, et al. Effects of calcitonin on rat extrapyramidal motor system: behavioral and biochemical data. Brain Res 1982;250:381-5.
57. Wright AF, Crichton DN, London JB, Morters JE, Stees CM. Beta-adrenoceptor binding defects in cell lines from families with manic-depressive disorder. Ann Hum Genet 1984;48:210-4.
58. Mathe AA, Agren H, Lindstrom L, Theodorsson E. Increased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorder. Neurosci Lett 1994;182:138-42.
59. de Beaurepaire R. Antagonism of calcitonin-induced anorexia by chronic, but not acute, tricyclic antidepressants in the rat. Brain Res 1992;581:165-7.
60. Fabbri A, Santoro C, Moretti C, Cappa M, Frajoli F, Di Julio GP, et al. The analgesic effect of calcitonin in humans: studies on the role of the opioid peptides. Int J Clin Pharmacol Ther Toxicol 1981;19(11):309.
61. Tagliaro F, Dorizzi R, Maffezzoli GF, Pacini L, Lo Casscio V, Ferrari S. Cerebrospinal fluid calcitonin levels after peripheral injection of human calcitonin. In: Pecile A, editor. Calcitonin 1984: chemistry, physiology, pharmacology and clinical aspects. Proceedings of an international Symposium on Calcitonin, 1984 Oct 2-4; Milan, Italy, p. 279-86.
62. Morimoto S, Nishimura J, Miyauchi A, Takai S, Okader Y, Onishi T, et al. Calcitonin in plasma and Cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier. J Clin Endocrinol Metab 1982;55(3):594.
63. Ustdal M, Dogan P, Soyeur A, Terzi S. Treatment of migraine in with salmon calcitonin: effects on plasma beta-endorphin, ACTH, and cortisol levels. Biomed Pharmacother 1989;43:687.
64. Overgaard K, Agnusdei D, Hansen MA, Maioli E, Christiansen C, Gennari C. Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and post-menopausal women. J Clin Endocrinol Metab 1991;72:344.
65. Allan E Calcitonin in the treatment of intractable pain from advanced malignancy. Pharmatherapeutica 1983;3:482-6.
66. Ceda GP, Denti L, Ceresini G, Rastelli G, Dotti C, Cavalieri S, et al. Calcitonin inhibition of growth hormone-releasing-hormone-induced GH secretion in normal men. Acta Endocrinol 1989;120:416-22.
67. Looij BJ Jr, Roelfsema F, Van der heide D, Frolich M, Souverijn JH, Nieuwenhuijzar Kruseman AC. The effect of calcitonin on growth hormone secretion in man. Clin Endocrinol 1988;29:517-27.
68. Looij BJ Jr, Roelfsema F, Frolich M. The effect of calcitonin on growth hormone secretion in acromegaly. Clin Endocrinol 1989;31:573-9.
69. Mitsuma T, Nogimori T, Chaya M. Peripheral administration of eel calcitonin inhibits thyrotropin secretion in rats. Eur J Pharmacol 1984;102(1):123-8.
70. Zofkova I, Bednar J. Calcitonin inhibits TRH-induced TSH secretion. Exp Clin Endocrinol 1984;83:263-8.
71. Laurian L, Oberman Z, Graf E, Gilad S, Hoerer E, Simantov R. Calcitonin induced increase in ACTH, beta-endorphin and cortisol secretion. Horm Metab Res 1986;18:268-71.
72. van Houten M, Posner BI. Circumventricular organs: receptors and mediators of direct hormone action on brain. In: Szabo A, editor. Advances in metabolic disorders vol. 10. New York: Academic Press; 1983. p. 269-89.
73. Pietrowsky R, Dentier M, Fehm HL, Born J. Effects of calcitonin on human auditory and visual evoked brain potentials. Psychopharmacology 1992;107:50-4.
74. Egeland JA, Gerhard DS, Pauls DC, Sussex JN, Kidd KK, Allen CR, et al. Bipolar affective disorder linked to DNA markers on chromosome 11. Nature 1987;325:783-7.